SuperworthDecoy Therapeutics shares outstanding DCOY
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 532K
- On a year earlier
- +4410.5%
- more shares
Decoy Therapeutics had 532K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4410.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 8K | +193% |
| FY2023 | 2.7K | +75% |
| FY2022 | 1.6K | +25% |
| FY2021 | 1.3K | +118% |
| FY2020 | 577 | +412% |
| FY2019 | 113 | +461% |
| FY2018 | 20 | +2% |
| FY2017 | 20 | +6% |
| FY2016 | 18 | +7% |
| FY2015 | 17 | +655% |
| FY2014 | 2 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 532K | +4410% | |
| Q1 FY26 | 532K | +7370% | |
| Q3 FY25 | 40.1K | +464% | |
| Q2 FY25 | 11.8K | +254% | |
| Q1 FY25 | 7.1K | +144% | |
| Q4 FY24 | 8K | +193% | |
| Q3 FY24 | 7.1K | +173% | |
| Q2 FY24 | 3.3K | +77% | |
| Q1 FY24 | 2.9K | +75% | |
| Q4 FY23 | 2.7K | +75% | |
| Q3 FY23 | 2.6K | +67% | |
| Q2 FY23 | 1.9K | +27% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Decoy Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.